Opiodur (Fentanyl)

Opiodur is an opioid analgesic that acts on the central nervous system to manage severe pain conditions.

• Cancer‑related pain: provides continuous opioid analgesia for patients with breakthrough pain despite other therapies.
• Post‑surgical pain: offers sustained pain relief during the postoperative recovery period when oral opioids are insufficient.
• Chronic non‑cancer pain: delivers long‑acting analgesia for conditions such as severe osteoarthritis or neuropathic pain in opioid‑tolerant individuals.
• Palliative‑care pain: maintains comfort in end‑of‑life care where stable plasma levels are required.
• Acute severe trauma trauma: stabilizes pain levels in patients with major injuries awaiting definitive treatment.

• Fentanyl binds with high affinity to the mu‑opioid receptors in the central nervous system, inhibiting the release of neurotransmitters that transmit pain signals. This receptor activation reduces neuronal excitability and modifies pain perception, producing potent analgesic effects while also causing sedation and respiratory depression at higher concentrations.

Adverse reactions to fentanyl may vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach often reported.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sleepiness or reduced alertness.
• Dizziness: sensation of light‑headedness or imbalance.
• Dry mouth: reduced salivation causing a parched feeling.
• Itching: mild skin pruritus at the application site.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Cardiac arrest: sudden loss of heart function.
• Anaphylaxis: severe allergic reaction with hives, swelling, and airway compromise.
• Seizures: convulsive episodes in susceptible individuals.
• Local skin necrosis: tissue death at the patch site.

When using Opiodur, careful monitoring and adherence to safety guidelines are essential.

• Titration: adjust dose gradually under medical supervision to avoid overdose.
• Opioid tolerance: confirm patient is opioid‑tolerant before initiating therapy.
• Respiratory monitoring: watch for signs of slowed breathing, especially after dose changes.
• Concomitant CNS depressants: avoid or limit use with alcohol, benzodiazepines, or other sedatives.
• Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Fentanyl may interact with several other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can increase fentanyl plasma levels and risk of respiratory depression.
• CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): additive sedation and respiratory depression.
• MAO inhibitors: may precipitate severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce fentanyl concentrations, decreasing analgesic effect.
• Anticholinergic agents: can worsen constipation.
• Diuretics: may enhance hypotensive effects.